No Data
Express News | guanhao biotech: Some of the shares held by the controlling shareholder will be auctioned judicially.
guanhao biotech (300238.SZ): the company has temporarily suspended the CAR-T project
Guanhao biotech (300238.SZ) stated on the investor interaction platform on November 4 that the company has temporarily suspended the CAR-T project.
Guan Hao Biology: Report for the third quarter of 2024
The concept of genetic testing in A-shares is rising, and Guanhao Biotech has hit the limit.
Guanhao Biotech hit the limit up, Vcanbio Cell & Gene Engineering Corp.,Ltd. closed at the limit, Canature Health Technology, Nanjing Xinjiekou Department Store, Tellgen Corporation, Xi'an International Medical Investment all saw significant volume increase.
A-share abnormal fluctuations | Warning of risks, guanhao biotech plunges more than 11%.
Guanhao Biotech (300238.SZ), which rose by the daily limit of 20 centimeters yesterday, dropped more than 11%, ranking first in the market's decline. It is currently trading at 10.47 yuan, with a total market value of less than 3 billion yuan. Guanhao Biotech announced after the market closed yesterday that the cumulative deviation of the closing price of the company's stock for three consecutive trading days from August 29th to September 2nd has reached 30%, causing abnormal fluctuations in the trading of the company's stock, and no significant undisclosed information has been found. It is worth noting that the company's half-year revenue and net profit have both declined, and more than 20% of the shares have been pledged.
Express News | Guanhao Biotech: There are no significant matters that the company should disclose but has not disclosed.
